community acquired pneumonia

A national confidential enquiry into community acquired pneumonia deaths in young adults in England and Wales
J C G Simpson, J T Macfarlane, J Watson, M A Woodhead

Thorax Dec 2000, 55 (12) 1040-1045; DOI: 10.1136/thorax.55.12.1040
Leucocyte response and anti-inflammatory cytokines in community acquired pneumonia
U K Kolling, F Hansen, J Braun, L Rink, H A Katus, K Dalhoff

Thorax Feb 2001, 56 (2) 121-125; DOI: 10.1136/thorax.56.2.121
Severity prediction rules in community acquired pneumonia: a validation study
W S Lim, S Lewis, J T Macfarlane

Thorax Mar 2000, 55 (3) 219-223; DOI: 10.1136/thorax.55.3.219
Circulating interleukin 6 and interleukin 10 in community acquired pneumonia
P Glynn, R Coakley, I Kilgallen, N Murphy, S O’Neill

Thorax Jan 1999, 54 (1) 51-55; DOI: 10.1136/thx.54.1.51
Development and validation of a short questionnaire in community acquired pneumonia
R El Moussaoui, B C Opmeer, P M M Bossuyt, P Speelman, C A J M de Borgie, J M Prins

Thorax Jul 2004, 59 (7) 591-595; DOI: 10.1136/thx.2003.015107
Pneumococcal serotype trends, surveillance and risk factors in UK adult pneumonia, 2013–18
Harry Pick, Priya Daniel, Chamira Rodrigo, Thomas Bewick, Deborah Ashton, Hannah Lawrence, Vadsala Baskaran, Rochelle C Edwards-Pritchard, Carmen Sheppard, Seyi D Eletu, Samuel Rose, David Litt, Norman K Fry, Shamez Ladhani, Meera Chand, Caroline Trotter, Tricia M McKeever, Wei Shen Lim

Thorax Jan 2020, 75 (1) 38-49; DOI: 10.1136/thoraxjnl-2019-213725

Main menu